
Trent R. Clarke
Examiner (ID: 14054, Phone: (571)272-2904 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651 |
| Total Applications | 513 |
| Issued Applications | 176 |
| Pending Applications | 78 |
| Abandoned Applications | 273 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18903043
[patent_doc_number] => 20240018528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => A TUNABLE PHOSPHORYLATION-BASED FEEDBACK CONTROLLER OF MAMMALIAN GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/039583
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -92
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039583
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039583 | A TUNABLE PHOSPHORYLATION-BASED FEEDBACK CONTROLLER OF MAMMALIAN GENE EXPRESSION | Dec 1, 2021 | Pending |
Array
(
[id] => 20173181
[patent_doc_number] => 12391915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Maintenance of differentiated cells with laminins
[patent_app_type] => utility
[patent_app_number] => 17/511079
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 3838
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511079 | Maintenance of differentiated cells with laminins | Oct 25, 2021 | Issued |
Array
(
[id] => 17385920
[patent_doc_number] => 20220033772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/501775
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501775
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501775 | Lyophilized compositions containing umbilical cord lining stem cells conditioned medium | Oct 13, 2021 | Issued |
Array
(
[id] => 18787263
[patent_doc_number] => 20230375528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => SCREENING METHOD FOR THE IDENTIFICATION OF NOVEL THERAPEUTIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/248022
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248022
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248022 | SCREENING METHOD FOR THE IDENTIFICATION OF NOVEL THERAPEUTIC COMPOUNDS | Oct 5, 2021 | Pending |
Array
(
[id] => 17382999
[patent_doc_number] => 20220030851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => MODULATING ISCHEMIC INJURY
[patent_app_type] => utility
[patent_app_number] => 17/494690
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494690
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494690 | MODULATING ISCHEMIC INJURY | Oct 4, 2021 | Pending |
Array
(
[id] => 18690229
[patent_doc_number] => 20230320370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => METHOD OF PRODUCING PROCESSED PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/044453
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044453
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044453 | METHOD OF PRODUCING PROCESSED PROTEIN | Sep 8, 2021 | Pending |
Array
(
[id] => 19075308
[patent_doc_number] => 11944651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Antimicrobial and antiviral agent, antimicrobial and antiviral member, and method for producing antimicrobial and antiviral agent
[patent_app_type] => utility
[patent_app_number] => 17/468765
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4380
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17468765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/468765 | Antimicrobial and antiviral agent, antimicrobial and antiviral member, and method for producing antimicrobial and antiviral agent | Sep 7, 2021 | Issued |
Array
(
[id] => 17441852
[patent_doc_number] => 20220062357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHOD AND COMPOSITION AGAINST VIRUS INFECTIONS WITH ACTIVATED INNATE LYMPHOID CELLS (ILCS)
[patent_app_type] => utility
[patent_app_number] => 17/409962
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/409962 | METHOD AND COMPOSITION AGAINST VIRUS INFECTIONS WITH ACTIVATED INNATE LYMPHOID CELLS (ILCS) | Aug 23, 2021 | Abandoned |
Array
(
[id] => 17244671
[patent_doc_number] => 20210364414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => APPARATUS AND METHOD FOR DETECTING CELLS OR PARTICLES IN A FLUID CONTAINER
[patent_app_type] => utility
[patent_app_number] => 17/396530
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396530
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396530 | Apparatus and method for detecting cells or particles in a fluid container | Aug 5, 2021 | Issued |
Array
(
[id] => 19869886
[patent_doc_number] => 12262719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Use of lactic acid bacteria for preparing fermented food products with increased natural sweetness
[patent_app_type] => utility
[patent_app_number] => 17/389986
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16178
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389986
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/389986 | Use of lactic acid bacteria for preparing fermented food products with increased natural sweetness | Jul 29, 2021 | Issued |
Array
(
[id] => 17228881
[patent_doc_number] => 20210355437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/390574
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390574 | FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS | Jul 29, 2021 | Pending |
Array
(
[id] => 17185517
[patent_doc_number] => 20210332402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => SERUM-FREE CELL CULTURE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 17/370389
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370389
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370389 | Serum-free cell culture medium | Jul 7, 2021 | Issued |
Array
(
[id] => 17200413
[patent_doc_number] => 20210340508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein
[patent_app_type] => utility
[patent_app_number] => 17/366419
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366419
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/366419 | Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein | Jul 1, 2021 | Pending |
Array
(
[id] => 18058316
[patent_doc_number] => 20220389402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHOD AND DEVICE FOR OPENING AN EXTERNAL LAYER STRUCTURE OF CELLS USING LASER
[patent_app_type] => utility
[patent_app_number] => 17/364868
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364868 | METHOD AND DEVICE FOR OPENING AN EXTERNAL LAYER STRUCTURE OF CELLS USING LASER | Jun 29, 2021 | Abandoned |
Array
(
[id] => 17297891
[patent_doc_number] => 20210393730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => HERBAL COMPOSITION FOR REDUCING URIC ACID AND THE USE IN REDUCING URIC ACID, BODY FAT, AND BLOOD GLUCOSE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/349061
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349061 | Herbal composition for reducing uric acid and the use in reducing uric acid, body fat, and blood glucose thereof | Jun 15, 2021 | Issued |
Array
(
[id] => 19067647
[patent_doc_number] => 20240102073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => GENETICALLY MODIFIED ORGANISMS FOR THE PRODUCTION OF STEROID DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/009057
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009057 | GENETICALLY MODIFIED ORGANISMS FOR THE PRODUCTION OF STEROID DERIVATIVES | Jun 7, 2021 | Pending |
Array
(
[id] => 18434499
[patent_doc_number] => 20230181793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => FUNCTIONALIZED POLY(GLYCEROL SEBACATE)S AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/923679
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923679
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923679 | FUNCTIONALIZED POLY(GLYCEROL SEBACATE)S AND USES THEREOF | May 16, 2021 | Pending |
Array
(
[id] => 17068594
[patent_doc_number] => 20210270809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => SYSTEM AND METHODS FOR IDENTIFYING CANCER CELL LINES HAVING ANTI-GROWTH ACTIVITY AGAINST OTHER CANCER CELL LINES
[patent_app_type] => utility
[patent_app_number] => 17/307821
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/307821 | SYSTEM AND METHODS FOR IDENTIFYING CANCER CELL LINES HAVING ANTI-GROWTH ACTIVITY AGAINST OTHER CANCER CELL LINES | May 3, 2021 | Abandoned |
Array
(
[id] => 18769441
[patent_doc_number] => 20230364205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 17/906818
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906818 | COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL CANCER | Mar 18, 2021 | Pending |
Array
(
[id] => 19263631
[patent_doc_number] => 20240207328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => USE OF PLASMODIUM IN PREPARATION OF ANTI-TUMOR PREPARATION FOR USE IN COMBINATION WITH RADIOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/288010
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288010 | USE OF PLASMODIUM IN PREPARATION OF ANTI-TUMOR PREPARATION FOR USE IN COMBINATION WITH RADIOTHERAPY | Mar 18, 2021 | Pending |